Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
An Overview of the Endocrine System01:10

An Overview of the Endocrine System

9.9K
The endocrine system, a complex network of glands, orchestrates physiological balance within the body through the production and secretion of hormones. These hormones are chemical messengers in intercellular communication, acting as conduits between the secretory cells and distant target sites. They traverse the circulatory system by being released into the extracellular fluid, and their impact is specific to cells possessing receptors for a particular hormone.
The endocrine system collaborates...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Neoadjuvant Induction Chemotherapy Prior to Chemoradiation on Survival and Surgical Outcomes in Real-World Esophageal Adenocarcinoma Cohort.

Cancers·2026
Same author

Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma.

Cancer research·2025
Same author

Exploration of machine learning techniques to examine the journey to neuroendocrine tumor diagnosis with real-world data.

Future oncology (London, England)·2021
See all related articles

Related Experiment Video

Updated: Oct 1, 2025

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.0K

Neuroendocrine Tumors: a Relevant Clinical Update.

Emma N Rizen1, Alexandria T Phan2,3

  • 1Phan & Associates LLC, 3730 Kirby Drive, Suite 1200, Houston, TX, 77098, USA.

Current Oncology Reports
|March 7, 2022
PubMed
Summary
This summary is machine-generated.

Recent advancements in neuroendocrine neoplasms (NENs) management offer improved patient outcomes. This review highlights practice-changing updates in NENs, focusing on new treatments and evolving understanding.

Keywords:
Carcinoid tumorClassificationEpidemiologyNeuroendocrine tumorReviewTreatment options

More Related Videos

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

19.1K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.1K

Related Experiment Videos

Last Updated: Oct 1, 2025

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

29.0K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

19.1K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.1K

Area of Science:

  • Neuroendocrine Oncology
  • Oncology
  • Neoplasms

Background:

  • Neuroendocrine neoplasms (NENs) are increasingly recognized, with improved classification and epidemiological understanding.
  • The field has evolved significantly since the initial description of carcinoid tumors.
  • Incidence and prevalence of NENs are rising, with patients living longer.

Purpose of the Study:

  • To summarize recent findings in neuroendocrine oncology.
  • To highlight clinically relevant and practice-changing updates in NEN management.

Main Methods:

  • Review of recent scientific literature and clinical findings.
  • Analysis of advancements in NEN classification and epidemiology.
  • Evaluation of new therapeutic strategies and molecular insights.

Main Results:

  • Neuroendocrine tumors (NETs) have largely replaced the term carcinoid tumor.
  • Significant progress in understanding molecular drivers of tumorigenesis.
  • Multiple new drug approvals for advanced NEN treatment.
  • Evolving clarity on the utility of NET biomarkers.

Conclusions:

  • Continued increase in NEN incidence and prevalence necessitates updated management strategies.
  • Enhanced understanding of molecular drivers and immunotherapy holds promise for transforming NEN care.
  • Ongoing research is crucial for further elevating the standard of care for NEN patients.